H Y402 C3

Lindsey A Chew1, Daniel Grigsby2, C Garren Hester3

  • 1Department of Ophthalmology, Duke Eye Center, Duke University Medical Center, Durham, NC 27710, USA; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.

概括

使用腺相关病毒 (AAV) 介导的切断补充因子H (tCFH) 传递的基因疗法对治疗补充介导的疾病如C3球球腺炎 (C3G) 和与年龄相关的黄斑变性 (AMD) 是有前途的. 这种方法恢复了补充通路功能,并在没有免疫排斥的小鼠模型中逆转了疾病.